Chemours CEO reports tax share withholding
Chemours Co director and Chief Executive Officer Denise Dignam reported a tax-withholding disposition of 477 shares of common stock on August 1, 2026 at $16.61 per share.
Rhea-AI Filing Summary
Chemours Co director and Chief Executive Officer Denise Dignam reported a tax-withholding disposition of 477 shares of common stock on August 1, 2026 at $16.61 per share. Shares were automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units; no shares were sold. Following this withholding, she reported 337,492.9016 shares held directly, including restricted stock units and dividend equivalent units.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock F1, F2 | 477 | $16.61 | $8K |
Footnotes (2)
- F1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
- F2. Includes directly owned shares, restricted stock units and dividend equivalent units.
Key Figures
Key Terms
restricted stock units financial
dividend equivalent units financial
Section 16(b) regulatory
Rule 16b-3 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Chemours (CC) CEO Denise Dignam report?
Was the Chemours (CC) CEO’s Form 4 transaction an open-market sale?
Does the Chemours (CC) CEO’s Form 4 mention Rule 16b-3 treatment?
AI-generated analysis. How Rhea-AI works. Not financial advice.